Skip to main content
. 2022 May 20;14(5):1097. doi: 10.3390/pharmaceutics14051097

Figure 19.

Figure 19

Biodegradable Hyaluronic acid MNs (HAMN) containing antibodies for the treatment of skin cancers. (a) Schematic of the aPD1 delivered by an MN patch loaded with physiologically self-dissociated NPs. (b) The blockade of PD-1 by aPD1 to activate the immune system to destroy skin cancer cells. [263]. (Reprinted with permission from Ref. [263]. Copyright 2016 American Chemical Society).